WO2020218727A3 - 갈색거저리 유충의 단백가수분해물로부터 분리된 펩타이드 및 이를 유효성분으로 포함하는 간 손상 예방 또는 치료용 조성물 - Google Patents

갈색거저리 유충의 단백가수분해물로부터 분리된 펩타이드 및 이를 유효성분으로 포함하는 간 손상 예방 또는 치료용 조성물 Download PDF

Info

Publication number
WO2020218727A3
WO2020218727A3 PCT/KR2020/002769 KR2020002769W WO2020218727A3 WO 2020218727 A3 WO2020218727 A3 WO 2020218727A3 KR 2020002769 W KR2020002769 W KR 2020002769W WO 2020218727 A3 WO2020218727 A3 WO 2020218727A3
Authority
WO
WIPO (PCT)
Prior art keywords
prevention
composition
liver injury
treatment
protein hydrolysate
Prior art date
Application number
PCT/KR2020/002769
Other languages
English (en)
French (fr)
Other versions
WO2020218727A2 (ko
WO2020218727A9 (ko
Inventor
이승욱
조혜린
Original Assignee
계명대학교 산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 계명대학교 산학협력단 filed Critical 계명대학교 산학협력단
Publication of WO2020218727A2 publication Critical patent/WO2020218727A2/ko
Publication of WO2020218727A3 publication Critical patent/WO2020218727A3/ko
Publication of WO2020218727A9 publication Critical patent/WO2020218727A9/ko

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/18Peptides; Protein hydrolysates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06043Leu-amino acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

본 발명은 갈색거저리 유충의 단백가수분해물로부터 분리된 펩타이드 및 이를 유효성분으로 포함하는 간 손상 예방 또는 치료용 조성물에 관한 것으로, 본 발명에 따르면, 갈색거저리 유충 단백가수분해물은 1 kDa 이하 크기의 생리활성 펩타이드를 포함하여 활성산소의 생성을 감소시키고 항산화 효소들의 발현과 활성을 증가시킴으로써 산화적 스트레스로부터 간세포를 효과적으로 보호하는 바, 간 손상 예방 또는 치료용 조성물, 간 손상 예방 또는 개선용 건강식품 조성물, 간 보호용 건강식품 조성물, 항산화용 건강식품 조성물 등으로 유용하게 활용될 수 있다.
PCT/KR2020/002769 2019-04-26 2020-02-26 갈색거저리 유충의 단백가수분해물로부터 분리된 펩타이드 및 이를 유효성분으로 포함하는 간 손상 예방 또는 치료용 조성물 WO2020218727A2 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020190049237A KR102252483B1 (ko) 2019-04-26 2019-04-26 갈색거저리 유충의 단백가수분해물로부터 분리된 펩타이드 및 이를 유효성분으로 포함하는 간 손상 예방 또는 치료용 조성물
KR10-2019-0049237 2019-04-26

Publications (3)

Publication Number Publication Date
WO2020218727A2 WO2020218727A2 (ko) 2020-10-29
WO2020218727A3 true WO2020218727A3 (ko) 2020-12-30
WO2020218727A9 WO2020218727A9 (ko) 2021-02-18

Family

ID=72941450

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2020/002769 WO2020218727A2 (ko) 2019-04-26 2020-02-26 갈색거저리 유충의 단백가수분해물로부터 분리된 펩타이드 및 이를 유효성분으로 포함하는 간 손상 예방 또는 치료용 조성물

Country Status (2)

Country Link
KR (1) KR102252483B1 (ko)
WO (1) WO2020218727A2 (ko)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112931627B (zh) * 2021-03-22 2023-05-09 内蒙古蒙牛乳业(集团)股份有限公司 一种抗氧化组合物和营养组合物及其制备方法
CN114470150B (zh) * 2021-12-13 2022-12-27 完美(广东)日用品有限公司 一种鸡源性小分子肽在制备预防和改善肝损伤及其继发症状产品中的应用及该产品

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011126163A1 (ko) * 2010-04-08 2011-10-13 주식회사 웰스킨 다이펩타이드를 포함하는 피부 미백용 조성물
KR20180055120A (ko) * 2016-11-16 2018-05-25 계명대학교 산학협력단 갈색거저리(Tenebrio molitor, mealworm) 유충의 단백 가수분해물, 이의 제조방법 및 이를 포함하는 항산화, 간 보호용 및 스트레스 감소용 식품 조성물

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100956249B1 (ko) 2008-04-14 2010-05-06 동화약품주식회사 정향 추출물을 유효성분으로 함유하는 고지혈증 치료시유발되는 간손상 치료용 약학조성물

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011126163A1 (ko) * 2010-04-08 2011-10-13 주식회사 웰스킨 다이펩타이드를 포함하는 피부 미백용 조성물
KR20180055120A (ko) * 2016-11-16 2018-05-25 계명대학교 산학협력단 갈색거저리(Tenebrio molitor, mealworm) 유충의 단백 가수분해물, 이의 제조방법 및 이를 포함하는 항산화, 간 보호용 및 스트레스 감소용 식품 조성물

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE Pubchem Compound 29 July 2006 (2006-07-29), "Ile-Glu", XP055768832, retrieved from NCBI *
DATABASE Pubchem Compound 29 July 2006 (2006-07-29), "Leu-Asp", XP055767953, retrieved from NCBI Database accession no. CID: 7019086 *
O. POWER, P. JAKEMAN, R. J. FITZGERALD: "Antioxidative peptides: enzymatic production, in vitro and in vivo antioxidant activity and potential applications of milk-derived antioxidative peptides", AMINO ACIDS., SPRINGER VERLAG., AU, vol. 44, no. 3, 1 March 2013 (2013-03-01), AU, pages 797 - 820, XP055767936, ISSN: 0939-4451, DOI: 10.1007/s00726-012-1393-9 *

Also Published As

Publication number Publication date
KR20200125239A (ko) 2020-11-04
WO2020218727A2 (ko) 2020-10-29
KR102252483B1 (ko) 2021-05-14
WO2020218727A9 (ko) 2021-02-18

Similar Documents

Publication Publication Date Title
Yoo et al. Bovine lactoferrin and lactoferricin TM inhibit tumor metastasis in mice
WO2020218727A3 (ko) 갈색거저리 유충의 단백가수분해물로부터 분리된 펩타이드 및 이를 유효성분으로 포함하는 간 손상 예방 또는 치료용 조성물
Joung et al. Antioxidative and antimicrobial activities of Lilium species extracts prepared from different aerial parts
Zheng et al. Analysis of the expression and antioxidative property of a peroxiredoxin 6 from Scophthalmus maximus
DE59911342D1 (de) Kosmetische wirkstoffzubereitung mit synergistisch erhöhtem radikalschutzfaktor
AU3657600A (en) Biologically active compounds of (ganoderma pfeifferi) dms 13239
WO2010141760A3 (en) Antimicrobial peptides
NO900185L (no) Preparater og fremgangsmaate for behandling eller forhindring av infeksjoner hos dyr.
WO2003091276A3 (en) Compositions and methods of use of peptides in combination with biocides and/or germicides
TW200616545A (en) Fungicidal compositions
CA2366065A1 (en) Topical cosmetic composition comprising bifidobacterium and plant extracellular matrix
EP4375382A3 (en) Bacterial strains having fungicidal activity, compositions comprising same and use thereof
WO2017213456A3 (ko) 멜라닌 생성 억제 활성을 갖는 펩타이드와 이를 포함하는 조성물
WO2008111562A1 (ja) 美白剤
WO2019045248A3 (ko) 주름 개선 활성을 나타내는 펩타이드 및 이의 용도
UA98649C2 (ru) Фунгицидная комбинация активных веществ, способ борьбы с фитопатогенными грибками при защите растений или материалов и семян
CN107087743A (zh) 一种抑菌抗氧化环保杀菌剂
Pasha Screening of small peptides from various germinating seeds having antimicrobial activity
WO2022104002A9 (en) Sars-cov-2 immunodominant peptide constructs and uses thereof
Shukla Therapeutic importance of peptides from marine source: A mini review
WO2019045467A3 (ko) 항산화 및 항고혈압 효과를 가지는 광어 연육 및 이의 제조방법
WO2012002762A3 (ko) 알러지성 질환의 치료 및 예방을 위한 펩타이드
WO2022013696A3 (en) Recombinant vaccinia virus
WO2021081110A3 (en) Peptides and use thereof
WO2020210647A3 (en) Methods and compositions for protection of bioprosthetic heart valve tissue from glycation and associated protein incorporation

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 20796125

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 20796125

Country of ref document: EP

Kind code of ref document: A2